Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
After 68 weeks, participants receiving a 2.4 mg weekly semaglutide dose experienced a 49% reduction in C-reactive protein (CRP), while those on a 1 mg weekly dose saw a 42% reduction compared to placebo
Most patients feel nothing in the first 4 to 8 hours
Gut 2013
Product Details Composition and Format Active Ingredient: Semaglutide Concentration: 5mg per vial Package Size: 10 vials per pack Form: Lyophilized powder for reconstitution Purity: 99% (HPLC verified) Analytical Verification High-Performance Liquid Chromatography (HPLC) tested Mass Spectrometry (MS) confirmed Certificate of Analysis (COA) provided with each batch Third-party laboratory verification Intended Professional Use This GLP-1 receptor agonist peptide is intended for purposes in metabolic studies
